Skip to main content

Table 1 Clinical Characteristics of 137 patients

From: Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma

Clinical characteristics

No. of patients

Age years

Mean 53 ± 12 (21–74)

Median 55

Sex

 Male

123

 Female

14

ALT (U/ml)

Mean 37 ± 30 (8–96)

AST (U/ml)

Mean 30 ± 15 (14–197)

TBiL (μmol/l)

Mean 15.9 ± 9.2 (6.1–48)

Median 13.4

Child-Pugh score

 A

129

 B

8

HBsAg

 Positive

114

 Negative

23

Liver cirrhosis

 No

31

 Yes

106

ICG-R15 (%)

Mean 7.2 ± 4.0 (1–22.4)

Median 6.6

AFP (ng/mL)

  ≤ 400

96

  > 400

41

Tumor diameter (cm)

Mean 5.5 ± 3.9 (1–15.7)

Median 4.5

No. of tumor

 Single

108

 Multiple

29

Portal vein tumor thrombosis

 No

109

 Yes

28

BCLC stage

0 + A

78

B + C

59

  1. ALT alanine transaminase, AST aspartate aminotransferase, TBiL total bilirubin, HBsAg hepatitis B surface antigen, ICG R15 min (%) indocyanine green 15 min retention rate, AFP alpha fetoprotein, BCLC Barcelona Clinic Liver Cancer staging system